β-agonists for ARDS: The dark side of adrenergic stimulation?

The Lancet

Volumn 379, Issue 9812, 2012, Pages 196-198

  Thompson, B Taylor ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE;

ACUTE LUNG INJURY; ADRENERGIC STIMULATION; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CATECHOLAMINE BLOOD LEVEL; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DIURESIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FLUID THERAPY; HEART ARRHYTHMIA; HEART FAILURE; HEART OUTPUT; HUMAN; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; LUNG ENDOTHELIUM; MORTALITY; NOTE; PATIENT CARE; POST HOC ANALYSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SEPTIC SHOCK; TACHYCARDIA; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR;

EID: 84856082872     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61845-X     Document Type: Note

References (14)

1. FG Smith, GD Perkins, S Gates for the BALTI-2 study investigators Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial Lancet 2011 10.1016/S0140-6736(11)61623-1 published online Dec 12.
2. HG Folkesson, MA Matthay Alveolar epithelial ion and fluid transport: recent progress Am J Respir Cell Mol Biol 35 2006 10 19 (Pubitemid 43993149)
3. LB Ware, MA Matthay Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome Am J Respir Crit Care Med 163 2001 1376 1383 (Pubitemid 32506602)
4. GD Perkins, DF McAuley, DR Thickett, F Gao The β-agonist lung injury trial (BALTI): a randomised placebo-controlled clinical trial Am J Respir Crit Care Med 173 2006 281 287 (Pubitemid 43209082)
5. AM Grant, DG Altman, AB Babiker for the DAMOCLES study group Issues in data monitoring and interim analysis of trials Health Technol Assess 9 2005 1 235
6. HP Wiedemann, AP Wheeler, GR Bernard for the National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Comparison of two fluid-management strategies in acute lung injury N Engl J Med 354 2006 2564 2575 (Pubitemid 43882352)
7. MA Matthay, RG Brower, S Carson et al. The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized β-2 agonist for treatment of acute lung injury Am J Respir Crit Care Med 184 2011 561 568
8. GD Perkins, DF McAuley Pro: β-agonist in acute lung injury - the end of the story? Am J Respir Crit Care Med 184 2011 503 504
9. L Papazian Con: β2-adrenergic agonists in ALI/ARDS - not recommended or potentially harmful? Am J Respir Crit Care Med 184 2011 504 506
10. C Gonzalez-Muñoz, T Fuente, S Medin-Aguerre, J Hernández- Cascales The increase in rat ventricular automaticity induced by salbutamol is mediated through β(1)- but not β(2)-adrenoceptors: role of phosphodiesterases Life Sci 88 2011 1095 1101
11. CA Schmittinger, B Wurzinger, M Deutinger et al. How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure Med Hypotheses 74 2010 460 465
12. M Singer, P Glynne Treating critical illness: the importance of first doing no harm PLoS Med 2 2005 e167
13. NM Novotny, T Lahm, TA Markel et al. β-blockers in sepsis: reexamining the evidence Shock 31 2009 113 119
14. DN Herndon, DW Hart, SE Wolf et al. Reversal of catabolism by beta-blockade after severe burns N Engl J Med 345 2001 1223 1229 (Pubitemid 34951485)